Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 6 |
2023 | 2 |
Search Results
7 results
Results by year
Page 1
STAT3-EMT axis in tumors: Modulation of cancer metastasis, stemness and therapy response.
Pharmacol Res. 2022 Aug;182:106311. doi: 10.1016/j.phrs.2022.106311. Epub 2022 Jun 15.
Pharmacol Res. 2022.
PMID: 35716914
Review.
Targeting PI3K/Akt signaling in prostate cancer therapy.
Hashemi M, Taheriazam A, Daneii P, Hassanpour A, Kakavand A, Rezaei S, Hejazi ES, Aboutalebi M, Gholamrezaie H, Saebfar H, Salimimoghadam S, Mirzaei S, Entezari M, Samarghandian S.
Hashemi M, et al. Among authors: hejazi es.
J Cell Commun Signal. 2022 Nov 11. doi: 10.1007/s12079-022-00702-1. Online ahead of print.
J Cell Commun Signal. 2022.
PMID: 36367667
Review.
Item in Clipboard
Curcumin in the treatment of urological cancers: Therapeutic targets, challenges and prospects.
Hashemi M, Mirzaei S, Barati M, Hejazi ES, Kakavand A, Entezari M, Salimimoghadam S, Kalbasi A, Rashidi M, Taheriazam A, Sethi G.
Hashemi M, et al. Among authors: hejazi es.
Life Sci. 2022 Nov 15;309:120984. doi: 10.1016/j.lfs.2022.120984. Epub 2022 Sep 20.
Life Sci. 2022.
PMID: 36150461
Review.
Item in Clipboard
SOX2 function in cancers: Association with growth, invasion, stemness and therapy response.
Mirzaei S, Paskeh MDA, Entezari M, Mirmazloomi SR, Hassanpoor A, Aboutalebi M, Rezaei S, Hejazi ES, Kakavand A, Heidari H, Salimimoghadam S, Taheriazam A, Hashemi M, Samarghandian S.
Mirzaei S, et al. Among authors: hejazi es.
Biomed Pharmacother. 2022 Dec;156:113860. doi: 10.1016/j.biopha.2022.113860. Epub 2022 Oct 20.
Biomed Pharmacother. 2022.
PMID: 36272267
Free article.
Review.
Item in Clipboard
siRNA and targeted delivery systems in breast cancer therapy.
Mirzaei S, Paskeh MDA, Entezari M, Bidooki SH, Ghaleh VJ, Rezaei S, Hejazi ES, Kakavand A, Behroozaghdam M, Movafagh A, Taheriazam A, Hashemi M, Samarghandian S.
Mirzaei S, et al. Among authors: hejazi es.
Clin Transl Oncol. 2023 May;25(5):1167-1188. doi: 10.1007/s12094-022-03043-y. Epub 2022 Dec 23.
Clin Transl Oncol. 2023.
PMID: 36562927
Review.
Item in Clipboard
The pharmacological and biological importance of EZH2 signaling in lung cancer.
Entezari M, Taheriazam A, Paskeh MDA, Sabouni E, Zandieh MA, Aboutalebi M, Kakavand A, Rezaei S, Hejazi ES, Saebfar H, Salimimoghadam S, Mirzaei S, Hashemi M, Samarghandian S.
Entezari M, et al. Among authors: hejazi es.
Biomed Pharmacother. 2023 Apr;160:114313. doi: 10.1016/j.biopha.2023.114313. Epub 2023 Feb 3.
Biomed Pharmacother. 2023.
PMID: 36738498
Free article.
Review.
Item in Clipboard
LncRNA-miRNA axis in tumor progression and therapy response: An emphasis on molecular interactions and therapeutic interventions.
Entezari M, Taheriazam A, Orouei S, Fallah S, Sanaei A, Hejazi ES, Kakavand A, Rezaei S, Heidari H, Behroozaghdam M, Daneshi S, Salimimoghadam S, Mirzaei S, Hashemi M, Samarghandian S.
Entezari M, et al. Among authors: hejazi es.
Biomed Pharmacother. 2022 Oct;154:113609. doi: 10.1016/j.biopha.2022.113609. Epub 2022 Aug 27.
Biomed Pharmacother. 2022.
PMID: 36037786
Free article.
Review.
Item in Clipboard
Cite
Cite